Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
FEBS Lett ; 574(1-3): 145-50, 2004 Sep 10.
Article in English | MEDLINE | ID: mdl-15358555

ABSTRACT

We identified a novel mutation Ala178fs/105 missing S3-S6 and C-terminus portions of KCNQ1 channel. Ala178fs/105-KCNQ1 expressed in COS-7 cells demonstrated no current expression. Co-expression with wild-type (WT) revealed a dominant-negative effect, which suggests the formation of hetero-multimer by mutant and WT. Confocal laser microscopy displayed intracellular retention of Ala178fs/105-KCNQ1 protein. Co-expression of the mutant and WT also increased intracellular retention of channel protein compared to WT alone. Our findings suggest a novel mechanism for LQT1 that the truncated S1-S2 KCNQ1 mutant forms hetero-multimer and cause a dominant-negative effect due to trafficking defect.


Subject(s)
Potassium Channels, Voltage-Gated , Potassium Channels/metabolism , Adolescent , Animals , Base Sequence , COS Cells , DNA Primers , Female , Genes, Dominant , Humans , KCNQ Potassium Channels , KCNQ1 Potassium Channel , Microscopy, Confocal , Potassium Channels/genetics , Protein Transport
2.
Heart Vessels ; 19(3): 137-43, 2004 May.
Article in English | MEDLINE | ID: mdl-15168062

ABSTRACT

A Na(+)-channel blocker, cibenzoline, blocks the delayed rectifier potassium current ( I(k)), but its detailed action on the rapidly activating component ( I(kr)) of I(k) encoded by the human ether-a-go-go-related gene ( HERG) has not been clarified. We examined the effects of cibenzoline on stably expressed HERG current in HEK293 cells recorded by the patch-clamp technique of whole-cell configuration. Cibenzoline blocked HERG current expressed in HEK293 cells with IC(50) = 3.7 +/- 0.963 micro M and Hill coefficient = 0.74 +/- 0.12. Voltage-depended activation was shifted in a negative direction by cibenzoline. No block or minor block was induced at test depolarization of -40 to -30 mV, and the block increased with depolarization reaching a plateau at 0 mV without a further increase at positive voltages. Voltage-dependent activation of HERG currents became faster at negative test voltages but there were no changes at positive voltages after cibenzoline. No frequency-dependent block of HERG tail current by cibenzoline after equilibration was noted between 1.33 and 0.2 Hz. Steady-state inactivation of the HERG current was shifted in a negative direction by approximately 8 mV but the time constants of fast inactivation were little affected by cibenzoline. Cibenzoline blocks the I(kr)-like current reconstituted by HERG clone transfection with an IC(50) value comparable to therapeutic concentrations. Cibenzoline has a preferential affinity, at least, to the open state of the HERG channel with a rapid access to the binding site.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Imidazoles/pharmacology , Potassium Channels, Voltage-Gated , Potassium Channels/drug effects , Potassium Channels/genetics , Sodium Channel Blockers/pharmacology , Action Potentials/drug effects , Animals , Cell Line , ERG1 Potassium Channel , Ether-A-Go-Go Potassium Channels , Humans , Patch-Clamp Techniques , Transfection
3.
J Cardiovasc Pharmacol ; 42(3): 410-8, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12960687

ABSTRACT

PURPOSE: Pilsicainide, classified as a relatively pure Na+ channel blocker, occasionally causes QT prolongation, suggesting inhibitory actions on K+ currents. We studied effects of pilsicainide on the K+ channel current of the human ether-a-go-go-related gene (HERG) in heterologous expression system. METHODS: The Patch-clamp technique in whole-cell configuration was used to record the channel current of HERG stably expressed in HEK293 cells. RESULTS: Pilsicainide suppressed peak currents of HERG channel during depolarizing pulses and tail currents upon repolarization. Pilsicainide blocked HERG current with IC50 = 20.4 microM and Hill coefficient = 0.98. Voltage-dependent activation was shifted in a negative direction by approximately 10 mV by 10 to 20 microM pilsicainide. Block increased with depolarization to voltages between -20 and 0 mV and reached the maximum level at positive voltages to 0 mV without further increase. Following drug equilibration for 10 minutes (holding potential at -100 mV), the peak outward current upon the first depolarization showed time-dependent block; tail current block was maximal. Frequency-dependent block evaluated from tail current was absent with pulse frequencies of 1.33, 0.5, and 0.2 Hz. After a steady state block was achieved, time course of current activation and deactivation was slowed by pilsicainide, and steady-state inactivation and time course of fast inactivation were mildly affected. CONCLUSIONS: Pilsicainide blocks HERG current with a preferential affinity, at least, to the open state of the channels with a fast access to binding sites.


Subject(s)
Cation Transport Proteins , DNA-Binding Proteins , Lidocaine/analogs & derivatives , Lidocaine/pharmacology , Potassium Channels, Voltage-Gated , Potassium Channels/drug effects , Sodium Channel Blockers/pharmacology , Trans-Activators , Action Potentials/drug effects , Cells, Cultured , ERG1 Potassium Channel , Ether-A-Go-Go Potassium Channels , Humans , Patch-Clamp Techniques , Transcriptional Regulator ERG
SELECTION OF CITATIONS
SEARCH DETAIL
...